LFG
MYGN icon

Larson Financial Group’s Myriad Genetics MYGN Stock Holding History

Larson Financial Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274 Hold
48
– – ﹤0.01% 3570
2026
Q1 		$216 Buy
+48
New +$250 ﹤0.01% 3440
2025
Q2 		– Sell
-142
Closed -$1.26K – 3427
2025
Q1 		$1.26K Buy
142
+129
+992% +$1.55K ﹤0.01% 2317
2024
Q4 		$178 Hold
13
– – ﹤0.01% 2471
2024
Q3 		$356 Hold
13
– – ﹤0.01% 2217
2024
Q2 		$318 Buy
+13
New +$285 ﹤0.01% 1950

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Larson Financial Group's MYGN Position: Q2 2026 in Review

Larson Financial Group held its Myriad Genetics (MYGN) position steady in Q2 2026 at 48 shares worth $274. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Larson Financial Group first reported a position in MYGN in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.26K in Q1 2025. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Larson Financial Group held 48 shares of Myriad Genetics worth $274 as of Q2 2026.
  • Larson Financial Group left its Myriad Genetics share count unchanged in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3570 holding.
  • Larson Financial Group first reported a position in Myriad Genetics in Q2 2024 and has held it in 6 quarters since.
  • Larson Financial Group's Myriad Genetics position peaked at $1.26K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.